We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

107 hedge funds and large institutions have $243M invested in Surgalign Holdings, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 31 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

23,600% more call options, than puts

Call options by funds: $237K | Put options by funds: $1K

200% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 6

51% more capital invested

Capital invested by funds: $161M → $243M (+$82.2M)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

26% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 31

13% more funds holding

Funds holding: 95107 (+12)

Holders
107
Holders Change
+12
Holders Change %
+12.63%
% of All Funds
2.67%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.1%
New
18
Increased
39
Reduced
31
Closed
6
Calls
$237K
Puts
$1K
Net Calls
+$236K
Net Calls Change
+$236K

SRGA Hedge Fund Activity: Q2 2017 in Review

107 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q2 2017, worth a combined $243M — up 51% from $161M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new SRGA positions and 6 closed out — a net gain of 12 holders — while 39 added to existing stakes and 31 trimmed.

The largest buyer was Rutabaga Capital Management, opening a new position worth an estimated $4M. The largest seller was Kennedy Capital Management, cutting an estimated $2.96M.

  • 107 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q2 2017, up from 95 in Q1 2017.
  • Funds reported $243M of Surgalign Holdings, Inc. Common Stock stock for Q2 2017, up 51% quarter-over-quarter.
  • 18 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q2 2017 and 6 closed out, a net change of +12 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q2 2017 was Rutabaga Capital Management, an estimated $4M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q2 2017 was Kennedy Capital Management, an estimated $2.96M sold.

Based on aggregated 13F filings for Q2 2017.